SCHEMBL12812484

SCHEMBL12812484

NC1CN(c2cnc3ccc(-c4ccc(NC(=O)Cc5ccccc5)cc4)cc3n2)CCO1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ WNT3A P56704 5/20 0.43
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ NR4A1 P22736 1/20 0.40
▸ SLC2A1 P11166 1/20 0.40
▸ MCHR1 Q99705 1/20 0.40
▸ AKT1 P31749 2/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ HTT P42858 1/20 0.40
▸ ADK P55263 1/20 0.40
▸ PIK3CA P42336 2/20 0.40
▸ PIK3CD O00329 1/20 0.40
▸ PIK3CB P42338 1/20 0.40
▸ MTOR P42345 1/20 0.40
▸ PIK3CG P48736 1/20 0.40
▸ MCL1 Q07820 1/20 0.39
▸ MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1443172 0.90 SMN1; SMN2 (0.46) SMN1; SMN2WNT3AKDM4EALDH1A1MAPT
SCHEMBL1442767 0.88 SMN1; SMN2 (0.43) SMN1; SMN2WNT3AKDM4EALDH1A1MAPT
SCHEMBL12812516 0.88 WNT3A (0.46) SMN1; SMN2WNT3AKDM4EALDH1A1MAPT
SCHEMBL1442104 0.87 SMN1; SMN2 (0.59) SMN1; SMN2WNT3AKDM4EALDH1A1MAPT
SCHEMBL1442323 0.84 MCHR1 (0.47) SMN1; SMN2WNT3AKDM4EALDH1A1MAPT
SCHEMBL1443409 0.84 MAPT (0.56) SMN1; SMN2WNT3AKDM4EALDH1A1MAPT
SCHEMBL1442689 0.83 SMN1; SMN2 (0.56) SMN1; SMN2WNT3AKDM4EALDH1A1MAPT
SCHEMBL1442230 0.83 MCHR1 (0.45) SMN1; SMN2WNT3AKDM4EALDH1A1MAPT
SCHEMBL1442532 0.83 WNT3A (0.49) WNT3AKDM4EALDH1A1MAPTNR4A1
SCHEMBL1443678 0.83 KDM4E (0.44) SMN1; SMN2WNT3AKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011026579-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-03-10 — — WO disclosed
Send feedback